Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey Objectives: To develop evidence-based European League Against Rheumatism ...
1 Department of Rheumatology, University Hospital of Northern Norway, Tromsø, Norway 2 Department of Rheumatology, Rikshospitalet-Radiumhospitalet University Hospital, Oslo, Norway Correspondence to ...
Introduction Vaccination represents a cornerstone in mastering the COVID-19 pandemic. Data on immunogenicity and safety of messenger RNA (mRNA) vaccines in patients with autoimmune inflammatory ...
Objectives To determine the trends in incidence, prevalence and mortality of systemic lupus erythematosus (SLE) in a US population over four decades. Methods We identified all the patients with SLE in ...
2 Department of Medicine, Rheumatology Unit, Karolinska Institutet/Karolinska Hospital, Stockholm, Sweden 3 Unit of Clinical Immunology, Uppsala University/Akademiska Sjukhuset, Uppsala, Sweden 4 ...
OBJECTIVE To determine the efficacy of the individual components of physiotherapy in subjects with anterior knee pain. METHODS An observer blind, prospective, factorial design randomised controlled ...
Department of Rehabilitation Medicine, Faculty of Medicine and Allied Health Sciences, Erasmus University Rotterdam, PO box 1738, 3000 DR Rotterdam, the Netherlands Dr J M A Mens. Local injections of ...
Academic Rheumatology, Clinical Sciences Building, Nottingham City Hospital, Nottingham, UK Correspondence to: Dr Edward Roddy Academic Rheumatology, Clinical Sciences Building, Nottingham City ...
Aim: MRI provides unparalleled visualisation of all the anatomical structures involved in the osteoarthritis (OA) process. There is a need for reliable methods of quantifying abnormalities of these ...
Objective: To develop a composite score for measurement of disease activity in polymyalgia rheumatica (PMR) and assess its internal and external validity. Methods: A PMR activity score (AS) was ...
Correspondence to Professor Lisa K Stamp, Department of Medicine, University of Otago, Christchurch, P.O. Box 4345, Christchurch, New Zealand; lisa.stamp{at}cdhb.health.nz Objectives To determine the ...
Background Targeted inhibitors of B-cell activating factor (BAFF) have been evaluated in phase III trials in over 4000 patients with systemic lupus erythematosus (SLE). Post hoc analyses of these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results